Nina Bonekamp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Credit: Hans-Georg Sprenger Mitochondria are the energy suppliers of our body cells. These tiny cell components have their own genetic material, which triggers an inflammatory response when released into the interior of the cell. The reasons for the release are not yet known, but some cardiac and neurodegenerative diseases as well as the ageing process are linked to the mitochondrial genome. Researchers at the Max Planck Institute for Biology of Ageing and the CECAD Cluster of Excellence in Ageing research have investigated the reasons for the release of mitochondrial genetic material and fou...

How it works The drug attacks a component of the cell known as mitochondria. Mitochondria are the sites for generating energy in cells. Think of mitochondria as the powerhouse of a cell. Without them, cells lack energy and cellular building blocks necessary for normal tissue and organ function. The new compound prevents the genetic information within mitochondria from being read hence technically starving cancer cells. It has previously been difficult to target mitochondria for cancer treatment due to their key role in normal tissue function and the toxicity of drugs that target mitochondrial...

New drug inhibits growth of cancer cells ANI | Updated: Dec 23, 2020 12:21 IST Washington [US], December 23 (ANI): A recent study has found a newly developed compound that starves cancer cells by attacking their "power plants" - the so-called mitochondria. The new compound prevents the genetic information within mitochondria from being read. Researchers from the Max Planck Institute for Biology of Ageing in Cologne, the Karolinska Institute in Stockholm, and the University of Gothenburg report in their study that this compound could be used as a potentia...

New drug starves cancer cells by attacking mitochondria A newly developed compound starves cancer cells by attacking their "power plants" - the so-called mitochondria. The new compound prevents the genetic information within mitochondria from being read. Researchers from the Max Planck Institute for Biology of Ageing in Cologne, the Karolinska Institute in Stockholm and the University of Gothenburg report in their study that this compound could be used as a potential anti-tumor drug in the future; not only in mice but also in human patients. Mitochondria provide our cells with energy and cell...

Credit: Hauke S. Hillen A newly developed compound starves cancer cells by attacking their "power plants" - the so-called mitochondria. The new compound prevents the genetic information within mitochondria from being read. Researchers from the Max Planck Institute for Biology of Ageing in Cologne, the Karolinska Institute in Stockholm and the University of Gothenburg report in their study that this compound could be used as a potential anti-tumour drug in the future; not only in mice but also in human patients. Mitochondria provide our cells with energy and cellular building blocks necessary ...